Screener
Cytek Biosciences, Inc. CTKB Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s return on equity?
- Cytek Biosciences, Inc. (CTKB) reported return on equity of -23% in Q2 2026.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Cytek Biosciences, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude